TESTS ON DOMESTIC VACCINES
입력 2022.04.28 (15:17)
수정 2022.04.28 (16:45)
읽어주기 기능은 크롬기반의
브라우저에서만 사용하실 수 있습니다.
[Anchor Lead]
The National Institute of Health is set to find out whether domestically produced vaccines would be effective against future variants of COVID-19 that may follow after omicron. In order to prepare for the post-omicron era, the institute said it has launched a study where the amount of neutralizing antibodies, which can suppress infections, will be measured in an effort to determine vaccine efficacy.
The National Institute of Health is set to find out whether domestically produced vaccines would be effective against future variants of COVID-19 that may follow after omicron. In order to prepare for the post-omicron era, the institute said it has launched a study where the amount of neutralizing antibodies, which can suppress infections, will be measured in an effort to determine vaccine efficacy.
■ 제보하기
▷ 카카오톡 : 'KBS제보' 검색, 채널 추가
▷ 전화 : 02-781-1234, 4444
▷ 이메일 : kbs1234@kbs.co.kr
▷ 유튜브, 네이버, 카카오에서도 KBS뉴스를 구독해주세요!
- TESTS ON DOMESTIC VACCINES
-
- 입력 2022-04-28 15:17:13
- 수정2022-04-28 16:45:21
[Anchor Lead]
The National Institute of Health is set to find out whether domestically produced vaccines would be effective against future variants of COVID-19 that may follow after omicron. In order to prepare for the post-omicron era, the institute said it has launched a study where the amount of neutralizing antibodies, which can suppress infections, will be measured in an effort to determine vaccine efficacy.
The National Institute of Health is set to find out whether domestically produced vaccines would be effective against future variants of COVID-19 that may follow after omicron. In order to prepare for the post-omicron era, the institute said it has launched a study where the amount of neutralizing antibodies, which can suppress infections, will be measured in an effort to determine vaccine efficacy.
이 기사가 좋으셨다면
-
좋아요
0
-
응원해요
0
-
후속 원해요
0
이 기사에 대한 의견을 남겨주세요.